Insider and Institutional Ownership
60.6% of shares of all “Help supply services” companies are held by institutional investors. 22.3% of Atlantic International shares are held by company insiders. Comparatively, 16.9% of shares of all “Help supply services” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Risk and Volatility
Atlantic International has a beta of 1.76, suggesting that its share price is 76% more volatile than the S&P 500. Comparatively, Atlantic International’s peers have a beta of 1.14, suggesting that their average share price is 14% more volatile than the S&P 500.
Earnings & Valuation
This table compares Atlantic International and its peers top-line revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Atlantic International | $80,000.00 | -$5.63 million | -0.27 |
Atlantic International Competitors | $3.15 billion | $30.14 million | -14.48 |
Profitability
This table compares Atlantic International and its peers’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Atlantic International | N/A | -298.20% | -42.32% |
Atlantic International Competitors | -0.66% | 15.33% | 4.25% |
Summary
Atlantic International peers beat Atlantic International on 5 of the 9 factors compared.
Atlantic International Company Profile
Atlantic International Corp. engages in the design, development, and manufacture of genetic analysis technologies. Its services include RNA sequencing and DNA sequencing. The company was founded by William C. St. Laurent and Daniel R. Jones in 2013 and is headquartered in Billercia, MA.
Receive News & Ratings for Atlantic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlantic International and related companies with MarketBeat.com's FREE daily email newsletter.